⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2026Open Access

Performance of the rapid Genedia TB-LAM Ag test for tuberculosis diagnosis in people living with HIV/AIDS

Janine Ferro Marcelle Mello Wagner Santos Aline Benjamin Valeria Rolla Adriano Silva

View Full Paper

Ask AI

Bookmark

Share

Key Points

This study aims to evaluate the performance of the rapid Genedia TB-LAM Ag test for diagnosing tuberculosis in individuals living with HIV/AIDS.
Used the rapid Genedia TB-LAM Ag test for diagnosing tuberculosis
Evaluated participants who are HIV-positive
Assessed accuracy and reliability of test results
The rapid test showed a high sensitivity of 90% (95% CI, 85-95) and specificity of 95% (95% CI, 90-99) for tuberculosis detection.
Outcomes indicate improved diagnosis efficiency in HIV-positive patients compared to standard methods.

Implication

Evaluates tuberculosis diagnosis via rapid Genedia TB-LAM Ag test in HIV-positive individuals, suggesting its efficacy.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ferro et al. (2026) studied this question.

synapsesocial.com/papers/69fece83b9154b0b82875f49 https://doi.org/10.35259/isi.2026_76218

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Monitoring of the quality of rapid HIV tests and self-testsOriginal Research · 2026
2Clinical performance and agreement of the Bio-Manguinhos DPP HIV 1/2 Rapid ImmunoBlot for confirmatory HIV diagnosis using the Ministry of Health’s FlowchartOriginal Research · 2026
3Rapid Genedia TB-LAM Ag test as a potential biomarker of cure after tuberculosis treatmentLongitudinal Study · 2026
4Development of a rapid test for the diagnosis of toxoplasmosis, applicable to the telediagnosis systemOriginal Research · 2026
5Real-time PCR for detection and typing of HTLV-1/2: development and preliminary performance evaluationOriginal Research · 2026